Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Blood. 2013 Feb 14;121(7):1184-7. doi: 10.1182/blood-2012-08-452649. Epub 2012 Dec 14.
Telomere shortening is of pathogenic and prognostic importance in cancers. In the present study, we analyzed telomere length in 73 mantle cell lymphoma (MCL), 55 chronic lymphocytic leukemia (CLL), and 20 normal B-cell samples using quantitative PCR (Q-PCR) to study its association with disease characteristics and outcome. Telomere length was found to be highly variable in MCL (range, 2.2-13.8 kb; median, 4.3 kb). Telomere dysfunction in MCL was evident from comparison with normal B cells (median, 7.5 kb), but had no significant association with any biologic or clinical feature. This was in contrast to CLL, in which a significant correlation of short telomeres with poor prognostic subgroups was confirmed. There was a trend toward an increased number of genomic aberrations with shortening of telomeres in MCL. No difference in survival was observed between the groups with short and long telomeres, indicating that, as opposed to CLL, telomere length is not of prognostic relevance in MCL.
端粒缩短在癌症的发病机制和预后中具有重要意义。本研究采用实时定量 PCR(Q-PCR)方法分析了 73 例套细胞淋巴瘤(MCL)、55 例慢性淋巴细胞白血病(CLL)和 20 例正常 B 细胞样本的端粒长度,以研究其与疾病特征和预后的关系。MCL 中端粒长度的变异性很大(范围 2.2-13.8kb;中位数 4.3kb)。与正常 B 细胞相比(中位数 7.5kb),MCL 中端粒功能障碍明显,但与任何生物学或临床特征均无显著相关性。这与 CLL 形成鲜明对比,后者证实了短端粒与预后不良亚组之间存在显著相关性。在 MCL 中,随着端粒缩短,基因组异常的数量呈增加趋势。端粒短和长的组间生存无差异,表明与 CLL 不同,端粒长度在 MCL 中与预后无关。